Literature DB >> 14620320

Spectrum of cutaneous appendage tumors at Aga Khan University Hospital.

N Yaqoob1, Z Ahmad, S Muzaffar, M S Gill, I N Soomro, S H Hasan.   

Abstract

OBJECTIVE: To determine the frequency of various types of cutaneous appendage tumors in our practice.
METHOD: This is a partly retrospective and partly prospective study conducted at the Department of Pathology, Histopathology Section, The Aga Khan University Hospital, Karachi between 1st January 1997 and 31st December 2001.
RESULTS: One hundred sixty six skin appendage tumors were diagnosed during the study period. 87.3% were benign, while 12.6% were malignant. Male female ratio was almost equal. Mean age was 41.72 years. 37.34% showed eccrine differentiation, 14.45% showed apocrine differentiation and 41.56% showed pilosebaceous differentiation, 6.62% exhibited mixed differentiation. The 5 commonest tumors were pilomatricoma, nodular hidradenoma (eccrine acrospiroma), syringocystadenoma papilleferum, eccrine poroma and eccrine spiradenoma. The commonest malignant tumors were porocarcinoma and sebaceous carcinoma. Pilomatricoma were common in children.
CONCLUSION: Most of our findings roughly correlate with the western published data. However, commonest site for eccrine poromas in our study was head and neck. Also, not a single case of eccrine spiradenoma was seen in the first two decades of life. These findings differ significantly from western data.

Entities:  

Mesh:

Year:  2003        PMID: 14620320

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  2 in total

1.  Adnexal Tumors of Skin: An Experience at a Tertiary Care Center at Delhi.

Authors:  M Pujani; G B Madaan; Z S Jairajpuri; S Jetley; M J Hassan; S Khan
Journal:  Ann Med Health Sci Res       Date:  2016 Sep-Oct

2.  Histomorphological and Immunohistochemical Reappraisal of Cutaneous Adnexal Tumours: A Hospital Based Study.

Authors:  Prakriti Shukla; Uroos Fatima; Anil K Malaviya
Journal:  Scientifica (Cairo)       Date:  2016-02-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.